Screener
Roivant Sciences ROIV Litigation settlement receivable
Litigation settlement receivable at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept roiv:LitigationSettlementsReceivableCurrent.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
| Line item | June 30, 2026 | March 31, 2026 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $1,248,456 | $1,419,232 |
| Marketable securities | 2,593,626 | 2,872,601 |
| Litigation settlement receivable | 771,627 | 770,235 |
| Other current assets | 128,371 | 105,316 |
| Total current assets | 4,742,080 | 5,167,384 |
| Property and equipment, net | 11,320 | 11,986 |
| Operating lease right-of-use assets | 78,886 | 80,416 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Roivant Sciences's litigation settlement receivable?
- Roivant Sciences (ROIV) reported litigation settlement receivable of $771.63M in Q2 2026.
- What does litigation settlement receivable mean?
- Litigation settlement receivable as reported by Roivant Sciences Ltd. Common Shares.
Ask your AI about Roivant Sciences's litigation settlement receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude